Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Premier Diagnostic Health Services Inc. New Director and Stock Option Grant

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 8, 2015) -

NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA

Premier Diagnostic Health Services Inc. ("Premier" or the "Company") (CSE:PDH) previously announced that its shareholders elected G. Andrew Cooke to the board of Premier at the general meeting held on April 2, 2015. Premier is now providing some additional information regarding Mr. Cooke.

Andrew Cooke is a Chartered Accountant and has over 25 years of accounting and finance experience. He previously acted as treasurer of Lumbermens Mutual Group (formerly Kemper Insurance). He has also acted as an independent consultant to Cunningham Lindsey, Fairmont Specialty and TIG from 2002 to 2005, all of which are subsidiaries of Fairfax Financial. Mr. Cooke has been a director of Corner Market Capital U.S. Inc. since 2008 and a director of Sequant Re Holdings Limited since December 2014.

"Andrew's accounting and insurance background is an asset for Premier" stated Sanjeev Parsad, President and CEO. "With Premier's investment in Sequant Re, a reinsurance company, Andrew is a natural fit for the board of directors."

In connection with Mr. Cooke's appointment as a director, he was granted 40,000 incentive stock options, each exercisable to purchase one common share of the Company at $0.21 for a term of five years from the date of grant. The option grant is subject to any required approvals such as CSE and shareholder approval. Mr. Cooke's appointment as director is subject to approval by the CSE.

On behalf of the Board of Directors

Sanjeev Parsad, President, CEO and Director

The Canadian Securities Exchange (CSE) has not reviewed the adequacy or the accuracy of the contents of this document. Company information can be viewed here: www.cnsx.ca. Further information regarding the Company can be found on SEDAR at ww.sedar.com.

Premier Diagnostic Health Services Inc.
Sanjeev Parsad
President and CEO
(604) 678.9279
(604) 678.9115 ext 205 / Cell: (604) 612.3965
sparsad@premierdiagnostics.ca
www.premierdiagnostics.ca



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today